{"id":"https://openalex.org/W2890809656","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e15071","title":"Multi-platform characterization of cutaneous melanoma from patients treated with immune checkpoint inhibitors.","display_name":"Multi-platform characterization of cutaneous melanoma from patients treated with immune checkpoint inhibitors.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2890809656","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e15071","mag":"2890809656"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.e15071","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e15071","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.e15071","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014727979","display_name":"Dan Moldoveanu","orcid":"https://orcid.org/0000-0002-1191-9798","observed_orcids":["https://orcid.org/0000-0002-1191-9798"]},"institutions":[{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Dan Moldoveanu","raw_affiliation_strings":["McGill University, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029451334","display_name":"Mathieu Lajoie","orcid":"https://orcid.org/0000-0001-9162-086X","observed_orcids":["https://orcid.org/0000-0001-9162-086X"]},"institutions":[{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mathieu Lajoie","raw_affiliation_strings":["McGill University, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101026188","display_name":"Xiu Qing Huang","orcid":"https://orcid.org/0000-0002-1368-4080","observed_orcids":["https://orcid.org/0000-0002-1368-4080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiu Huang","raw_affiliation_strings":["KEW, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KEW, Inc., Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108388838","display_name":"Maria Lvova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Lvova","raw_affiliation_strings":["KEW, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KEW, Inc., Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091889508","display_name":"Julie Y. Tse","orcid":"https://orcid.org/0000-0001-8648-5288","observed_orcids":["https://orcid.org/0000-0001-8648-5288"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Y Tse","raw_affiliation_strings":["Tufts University School of Medicine, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tufts University School of Medicine, Boston, MA;","institution_ids":["https://openalex.org/I121934306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038572461","display_name":"Stephen R. Lyle","orcid":"https://orcid.org/0000-0001-5476-0740","observed_orcids":["https://orcid.org/0000-0001-5476-0740"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Lyle","raw_affiliation_strings":["KEW, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KEW, Inc., Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007863504","display_name":"Alexei I. Protopopov","orcid":"https://orcid.org/0000-0002-3156-1279","observed_orcids":["https://orcid.org/0000-0002-3156-1279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexei Protopopov","raw_affiliation_strings":["Kew Group Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kew Group Inc., Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Meaghan Russel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meaghan Russel","raw_affiliation_strings":["Kew Group Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kew Group Inc., Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087616570","display_name":"Matthew Dankner","orcid":"https://orcid.org/0000-0003-4869-5895","observed_orcids":["https://orcid.org/0000-0003-4869-5895"]},"institutions":[{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Matthew Dankner","raw_affiliation_strings":["McGill University, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089111286","display_name":"Sonia Victoria Del Rincon","orcid":"https://orcid.org/0000-0002-6350-0227","observed_orcids":["https://orcid.org/0000-0002-6350-0227"]},"institutions":[{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sonia Del Rincon","raw_affiliation_strings":["McGill University, Segal Cancer Center, Lady Davis Institute, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University, Segal Cancer Center, Lady Davis Institute, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I4405267356","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019294769","display_name":"L\u00e9on C.L.T. van Kempen","orcid":"https://orcid.org/0000-0003-0646-0705","observed_orcids":["https://orcid.org/0000-0003-0646-0705"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Leon Van Kempen","raw_affiliation_strings":["Department of Pathology, Molecular Pathology Center, Jewish General Hospital, McGill University, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Molecular Pathology Center, Jewish General Hospital, McGill University, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002072156","display_name":"Alan Spatz","orcid":"https://orcid.org/0000-0003-3020-1420","observed_orcids":["https://orcid.org/0000-0003-3020-1420"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Alan Spatz","raw_affiliation_strings":["Department of Pathology, Molecular Pathology Center, Jewish General Hospital, McGill University, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Molecular Pathology Center, Jewish General Hospital, McGill University, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048013287","display_name":"Wilson H. Miller","orcid":"https://orcid.org/0000-0002-7408-1574","observed_orcids":["https://orcid.org/0000-0002-7408-1574"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405278727","display_name":"Rossy Cancer Network","ror":"https://ror.org/00f3ctm49","country_code":"CA","type":"funder","lineage":["https://openalex.org/I4405278727"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Wilson H. Miller","raw_affiliation_strings":["Segal Cancer Center, Jewish General Hospital, Rossy Cancer Network, McGill University, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Segal Cancer Center, Jewish General Hospital, Rossy Cancer Network, McGill University, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405278727","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021101665","display_name":"Kevin Petrecca","orcid":"https://orcid.org/0000-0002-8140-6402","observed_orcids":["https://orcid.org/0000-0002-8140-6402"]},"institutions":[{"id":"https://openalex.org/I2801766832","display_name":"McGill University Health Centre","ror":"https://ror.org/04cpxjv19","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kevin Petrecca","raw_affiliation_strings":["McGill University Health Centre, Montr\u00e9al, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University Health Centre, Montr\u00e9al, QC, Canada;","institution_ids":["https://openalex.org/I2801766832"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009752659","display_name":"B\u00e9atrice Wang","orcid":"https://orcid.org/0009-0009-4200-3553","observed_orcids":["https://orcid.org/0009-0009-4200-3553"]},"institutions":[{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Beatrice Wang","raw_affiliation_strings":["McGill University, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022692949","display_name":"Sarkis H. Meterissian","orcid":"https://orcid.org/0000-0002-9586-3583","observed_orcids":["https://orcid.org/0000-0002-9586-3583","https://orcid.org/0009-0000-3453-6960"]},"institutions":[{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sarkis H. Meterissian","raw_affiliation_strings":["McGill University, Montr\u00e9al, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University, Montr\u00e9al, QC, Canada;","institution_ids":["https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051465114","display_name":"Kevin A. Watters","orcid":"https://orcid.org/0000-0002-2306-0773","observed_orcids":["https://orcid.org/0000-0002-2306-0773"]},"institutions":[{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kevin Watters","raw_affiliation_strings":["McGill University, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055921357","display_name":"Catalin Liviu Dragos Mihalcioiu","orcid":"https://orcid.org/0000-0003-4010-2012","observed_orcids":["https://orcid.org/0000-0003-4010-2012"]},"institutions":[{"id":"https://openalex.org/I4210088756","display_name":"Royal Victoria Hospital","ror":"https://ror.org/00arwy491","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210088756","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Catalin Liviu Dragos Mihalcioiu","raw_affiliation_strings":["Royal Victoria Hospital, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Victoria Hospital, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I4210088756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008921872","display_name":"Dana Vuzman","orcid":"https://orcid.org/0000-0002-9317-8582","observed_orcids":["https://orcid.org/0000-0002-9317-8582"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dana Vuzman","raw_affiliation_strings":["KEW, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KEW, Inc., Cambridge, MA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035229273","display_name":"Ian R. Watson","orcid":"https://orcid.org/0000-0002-6025-3080","observed_orcids":["https://orcid.org/0000-0002-6025-3080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian Watson","raw_affiliation_strings":["Goodman Cancer Research Centre, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Goodman Cancer Research Centre, Montreal, QC, Canada;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"e15071","last_page":"e15071"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.871999979019165},{"id":"https://openalex.org/keywords/immunotherapy-response-prediction","display_name":"immunotherapy response prediction","score":0.7440000176429749},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.9010000228881836},{"id":"https://openalex.org/keywords/immune-infiltration","display_name":"immune cell infiltration","score":0.47600001096725464},{"id":"https://openalex.org/keywords/eosinophils","display_name":"eosinophils","score":0.6639999747276306},{"id":"https://openalex.org/keywords/basophils","display_name":"basophils","score":0.9950000047683716},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.9950000047683716},{"id":"https://openalex.org/keywords/dna-copy-number","display_name":"DNA copy number","score":0.7179999947547913},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8106127977371216},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6275529861450195},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5957440733909607},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5623255372047424},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5223670601844788},{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.4776923954486847},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.47268444299697876},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.44283461570739746},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41254380345344543},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41149652004241943},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3730316758155823},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.e15071","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e15071","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.e15071","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4200412346","https://openalex.org/W3032399294","https://openalex.org/W3100266437","https://openalex.org/W2741763375","https://openalex.org/W4220773618","https://openalex.org/W4387747122","https://openalex.org/W3080682982","https://openalex.org/W3001796188","https://openalex.org/W3088170039","https://openalex.org/W2785351732"],"abstract_inverted_index":{"e15071":[0],"Background:":[1],"Therapeutics":[2],"targeting":[3],"inhibitory":[4],"immune":[5,117,137,166,199,255],"checkpoints":[6],"have":[7,78],"revolutionized":[8],"the":[9,153,249],"treatment":[10,20,221],"of":[11,18,35,49,67,76,92,109,127,148,165,171,245,252],"advanced":[12],"and":[13,23,40,87,169,187,202,214,233],"metastatic":[14,130],"melanoma.":[15],"Clinical":[16],"trials":[17],"dual":[19],"with":[21,33,64,136,219,230],"anti-CTLA4":[22],"anti-PD-1":[24],"monoclonal":[25],"antibodies":[26],"observed":[27],"up":[28],"to":[29,59,116,182,188,241,247,254,258],"57.6%":[30],"response":[31,39,94,115,235,253],"rates":[32],"11.5%":[34],"patients":[36,68,134],"achieving":[37],"complete":[38],"13.1%":[41],"having":[42],"stable":[43],"disease":[44],"for":[45],"over":[46,65],"12":[47],"months":[48],"follow-up":[50],"(Larkin":[51],"et":[52,98],"al.":[53,99],"2015).":[54],"However,":[55],"side":[56],"effects":[57],"continue":[58],"be":[60],"a":[61,70,113,123,242],"major":[62],"problem":[63],"40%":[66],"reporting":[69],"severe":[71],"adverse":[72],"event.":[73],"A":[74,101],"number":[75],"groups":[77],"identified":[79],"that":[80],"tumour":[81,184],"mutation":[82,185],"burden,":[83],"gene":[84,178],"expression":[85],"signatures":[86],"tumor":[88],"aneuploidy":[89],"are":[90],"predictors":[91],"immunotherapy":[93],"(reviewed":[95],"in":[96,142],"Sharma":[97],"2017).":[100],"significant":[102],"knowledge":[103,246],"gap":[104],"remains":[105],"regarding":[106],"which":[107],"combination":[108],"factors":[110],"best":[111],"predict":[112,183],"priori":[114],"checkpoint":[118,138,200,256],"inhibitors.":[119,139],"Methods:":[120],"We":[121],"performed":[122],"multi-platform":[124],"integrative":[125],"analysis":[126,170],"42":[128],"regional":[129],"melanoma":[131,192,261],"samples":[132],"from":[133,156],"treated":[135],"Platforms":[140],"included":[141],"this":[143],"study":[144,239],"were":[145,217,228],"focused":[146,176],"sequencing":[147,177],">400":[149],"cancer-associated":[150],"genes":[151],"using":[152],"CANCERPLEX":[154],"platform":[155],"Kew":[157],"Group":[158],"Inc.,":[159],"DNA":[160],"copy":[161],"number,":[162],"7-colour":[163],"immunofluorescence":[164],"infiltration":[167,197],"markers,":[168],"peripheral":[172],"blood.":[173],"Results:":[174],"Our":[175],"panel":[179],"was":[180],"shown":[181],"burden":[186],"accurately":[189],"identify":[190],"known":[191],"driver":[193],"mutations.":[194],"Tumour":[195],"lymphocyte":[196],"predicted":[198],"response,":[201,222],"highly":[203],"infiltrated":[204],"tumours":[205],"had":[206],"improved":[207,220],"survival":[208,232],"(p<0.05).":[209],"Furthermore,":[210],"elevated":[211],"pre-treatment":[212],"eosinophil":[213],"basophil":[215],"counts":[216],"associated":[218,229],"while":[223],"high":[224],"lactate":[225],"dehydrogenase":[226],"levels":[227],"poor":[231],"decreased":[234],"rates.":[236],"Conclusions:":[237],"This":[238],"adds":[240],"growing":[243],"body":[244],"understand":[248],"molecular":[250],"determinants":[251],"inhibitors":[257],"further":[259],"personalize":[260],"care.":[262]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2018-09-27T00:00:00"}
